Last update 01 Nov 2024

HASPIN x FLT3

Basic Info

Related Targets
HASPINFLT3

Related

1
Drugs associated with HASPIN x FLT3
HSK-205
Target
FLT3 x HASPIN
Mechanism
FLT3 inhibitors [+1]
Active Org.
Purdue UniversityPurdue University
Originator Org.
Purdue UniversityPurdue University
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HASPIN x FLT3
Login to view more data
100 Translational Medicine associated with HASPIN x FLT3
Login to view more data
0 Patents (Medical) associated with HASPIN x FLT3
Login to view more data
1
Literatures (Medical) associated with HASPIN x FLT3
RSC Medicinal Chemistry
Dual FLT3/haspin kinase inhibitor based on 3H-pyrazolo[4,3-f]quinoline scaffold with activities against acute myeloid leukemia

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free